Naik et al. [18] initially reported that JAM-A could reduce invasion and motility of breast cancer cell lines in vitro and JAM-A expression in breast cancer patients was negatively associated with tumor aggressiveness and metastasis. This evidence concerns the gene F11R and breast cancer.